文献速递儿科影像技术与安全MR

北美儿科医疗机构中钆基磁共振对比剂的使用及对脑钆沉积的认知情况

Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America.
PubMed 文献 · Pediatr Radiol · 2017-03-10

该研究于2016年1月至3月向5,390名儿科专业学会医生发送自愿封闭式问卷,调查儿科机构钆对比剂使用现状及放射科与转诊医生对脑钆沉积的认知。结果显示80%受访儿科医院使用大环状对比剂,58%在过去一年更换了对比剂(最常用钆特酸葡胺),放射科医生对脑钆沉积的知晓率高于非放射科医生(87% vs 26%,P<0.0001)。结论认为尽管许多儿科医院已转向或计划转向更稳定的大环状对比剂,但仍需对放射科和儿科转诊医生进行大量进一步教育。

要点

  • 80%受访儿科医院使用大环状对比剂,58%在过去一年更换对比剂,最常用钆特酸葡胺。
  • 放射科医生对脑钆沉积的知晓率高于非放射科医生(87% vs 26%,P<0.0001)。
  • 放射科医生处理患者询问的舒适度高于儿科转诊医生(48% vs 6%,P<0.0001)。

核心结论

  • 自发现脑钆沉积以来,许多儿科医院已转向或计划转向更稳定的大环状MR对比剂,最常用钆特酸葡胺;尽管如此,仍需对放射科医生和儿科转诊医生就GBCA及脑钆沉积进行大量进一步教育。

研究设计与样本

  • 研究为向5,390名儿科专业学会医生发送自愿封闭式问卷调查,调查时间为2016年1月至2016年3月,采用卡方检验和Fisher精确检验比较各专科间的应答分布。

诊断标准与关键数值

  • 80%受访儿科医院使用大环状对比剂。
  • 58%的医院在过去一年更换了对比剂,最常用钆特酸葡胺,最常见原因为脑钆沉积。
  • 23%的医院正在考虑更换对比剂,其中83%将换用钆特酸葡胺,最常见原因为脑钆沉积和安全性。
  • 放射科医生对脑钆沉积的知晓率高于非放射科医生(87% vs 26%,P<0.0001)。
  • 放射科医生和转诊医生表达的担忧程度相近(95%和89%)。

临床应用与阅片要点

  • 12%的放射科医生和2%的转诊医生报告有患者询问脑钆沉积问题。
  • 放射科医生处理患者询问的舒适度显著高于儿科转诊医生(48% vs 6%,P<0.0001)。
  • 儿科转诊医生申请的MRI数量与其对脑钆沉积的知识、所在医院使用的对比剂及与患者讨论脑钆沉积的舒适度相关(P<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Numerous recent articles have reported brain gadolinium deposition when using linear but not macrocyclic gadolinium-based contrast agents (GBCAs).

OBJECTIVE: To determine the current landscape of gadolinium use among pediatric institutions and the knowledge base of radiologists and referring providers with regard to GBCAs and brain gadolinium deposition.

MATERIALS AND METHODS: We e-mailed voluntary closed surveys to 5,390 physicians in various pediatric professional societies between January 2016 and March 2016. We used chi-square and Fisher exact tests to compare response distributions among specialties.

RESULTS: We found that 80% of surveyed pediatric hospitals use macrocyclic contrast agents. In the last year, 58% switched their agent, most commonly to gadoterate meglumine, with the most common reason being brain gadolinium deposition. Furthermore, surveys indicated that 23% of hospitals are considering switching, and, of these, 83% would switch to gadoterate meglumine; the most common reasons were brain gadolinium deposition and safety. Radiologists were more aware of brain gadolinium deposition than non-radiologist physicians (87% vs. 26%; P<0.0001). Radiologists and referring providers expressed similar levels of concern (95% and 89%). Twelve percent of radiologists and 2% of referring providers reported patients asking about brain gadolinium deposition. Radiologists were significantly more comfortable addressing patient inquiries than referring pediatric physicians (48% vs. 6%; P<0.0001). The number of MRIs requested by referring pediatric physicians correlated with their knowledge of brain gadolinium deposition, contrast agent used by their hospital, and comfort discussing brain gadolinium deposition with patients (P<0.0001).

CONCLUSION: Since the discovery of brain gadolinium deposition, many pediatric hospitals have switched to or plan to switch to a more stable macrocyclic MR contrast agent, most commonly gadoterate meglumine. Despite this, there is need for substantial further education of radiologists and referring pediatric providers regarding GBCAs and brain gadolinium deposition.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Mithal LB, Patel PS, Mithal D, et al. Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America. Pediatr Radiol. 2017. PMID: 28283727. doi:10.1007/s00247-017-3810-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。